Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by BILLMINERon Sep 29, 2010 11:58pm

233 Views

Post# 17510203

Halo

Sorry 25 cents, halo has way more upside potential than VMS. VMS sold the farm in that last deal. Too many shares out.

Halo is valued at a mere 7 or so million. THis company will be in the 2.00 range soon enough with only 18 million shares out and lots of ore in the ground. Plus they took on my property which will be a winner for sure. lol

<< Previous

Bullboard Posts

Next >>

Cameco raises uranium output as Q3 results surge